The joint cell death of apoptosis and pyroptosis highlights the potential of ZHPV16E7-GrB as a powerful tool in cancer immunotherapy, and especially pyroptosis, with its ability to provoke robust immune activation, may serve as a complementary mechanism to apoptosis, further amplifying the anti-tumor immune response. This evidence concerns the gene GZMB and neoplasm.